Our Investors
Meet some of the more than 80 shareholders who have invested in OptiRTP to help advance our mission — people from all walks of life who share a belief in the power of technology to improve health outcomes. Our investor community includes Olympic and Paralympic medalists, World Cup athletes, national coaches, members of the New Zealand Order of Merit (KNZM, MNZM), medical professionals, business leaders, and innovators — each united by a genuine commitment to helping others. Many first connected with OptiRTP after personally engaging with the technology, either themselves or through a loved one, and have since chosen to support our disciplined approach to building a regulated, evidence-led health technology platform informed by real-world data.
Sir Graham & Lady Raewyn Henry
“Raewyn and I invested to help fast track the product and improve people’s quality of life.”
Heath Mills
“I’m passionate about player wellbeing and putting athletes’ needs first, both of which align to the values and vision of OptiRTP.”
Grant Sharman MNZM
“I use it, it works. Like the Remington guy, I like it so much I bought the company. Why wouldn’t I invest?”
Mark Carter
“I invested within a couple of months of using it due to a marked increase in energy levels.”
Simon Tremain
“The reason I invested in OptiRTP was quite simple — the technology seemed light years ahead of any medical help I had ever experienced and the growth opportunities seemed phenomenal.”
Natalie & Hayden Allen
“So excited we can finally be a part of OptiRTP’s incredible journey! We’ve watched and listened from the outside for so long, desperately wanting to help, and now we’re so happy the day has come.”
Jonathan Going
“With a passionate leadership team behind an innovative product that can truly change people’s lives, I knew I had to be part of this journey. This is why I’ve invested in both OptiRTP and the future health of my family.”
Belinda Fellowes
“OBST gave me my life back. It took just three weeks to permanently change four years of misery and suffering, to become the person I had been.”
Dr Andrew MacGill
“I invested in OptiRTP because it worked for me, the team are genuine, honest and dedicated. I’m very excited to see how things progress over the next few years.”
Matt Blair
“I was drawn to OptiRTP because of its focus on nervous system–related research and the way it brings together long-standing concepts with modern science and technology. From an investment perspective, I’ve been impressed by the team’s discipline, their commitment to evidence, and the care they’re taking in how they build and validate the platform.”
Join Our Investment Community
Be part of the future of pain management and recovery. Learn more about investment opportunities with OptiRTP.
LEARN MOREThe experiences shared on this page reflect individual outcomes. OBST is a registered FDA Class I device. It is not intended to diagnose, cure, or treat medical conditions. Individual results may vary.
